The invention provides novel 2 adrenergic receptor agonist
compounds. The invention also provides pharmaceutical compositions comprising such
compounds, methods of using such compounds to treat diseases associated with 2
adrenergic receptor activity, and processes and intermediates useful for
preparing such compounds.